Diabetes care cascade in Ukraine: an analysis of breakpoints and opportunities for improved diabetes outcomes

被引:0
作者
Robyn Margaret Stuart
Olga Khan
Romesh Abeysuriya
Tetyana Kryvchun
Viktor Lysak
Alla Bredikhina
Nina Durdykulyieva
Volodymyr Mykhailets
Elvira Kaidashova
Olena Doroshenko
Zara Shubber
David Wilson
Feng Zhao
Nicole Fraser-Hurt
机构
[1] University of Copenhagen,Department of Mathematical Sciences
[2] The World Bank Group,undefined
[3] Monash University,undefined
[4] Department of Health,undefined
来源
BMC Health Services Research | / 20卷
关键词
Diabetes; Care cascades; Optimization; Modeling; Service delivery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 21 条
[1]  
Seuring T(2016)A pooled analysis of 751 population-based studies with 4.4 million participants Lancet 387 1513-1530
[2]  
Archangelidi O(2015)The economic costs of type 2 diabetes: a global systematic review Pharmacoeconomics 33 811-831
[3]  
Suhrcke M(2019)Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys PLoS Med 16 681-689
[4]  
Manne-Goehler J(2014)A cascade of care for diabetes in the United States: visualizing the gaps Ann Intern Med 161 465-470
[5]  
Ali MK(2017)Prevalence and unmet need for diabetes care across the care continuum in a national sample of south African adults: evidence from the SANHANES-1, 2011-2012 PLoS One 12 1124-1136
[6]  
Stokes A(2016)Ukrainian experience of health care for patients with diabetes Wiad Lek 69 e190-e198
[7]  
Матюха ЛФ(2011)Health care provision for people with diabetes and postgraduate training of diabetes specialists in eastern European countries J Diabetes Sci Technol 5 365-376
[8]  
Doničová V(2018)The global optima HIV allocative efficiency model: targeting resources in efforts to end AIDS Lancet HIV 5 98-102
[9]  
Brož J(2015)Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization JAIDS J Acquir Immune Defic Syndr 69 331-358
[10]  
Sorin I(2018)How should HIV resources be allocated? Lessons learnt from applying optima HIV in 23 countries J Int AIDS Soc 21 172-183